Mirae Asset Global Investments Co., Ltd. Guardant Health, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,117 shares of GH stock, worth $192,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,117
Previous 4,449
7.46%
Holding current value
$192,428
Previous $102,000
22.55%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
115MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$563 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$525 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$300 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$255 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$244 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.78B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...